Predicting treatment responsiveness-resistiveness in a population of depressed patients.
D000928:Antidepressive Agents / Q000627:therapeutic use*; D002746:Chlorpromazine / Q000627:therapeutic use; D003863:Depression / Q000175:diagnosis / Q000188:drug therapy*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D004644:Emotions; D005069:Evaluation Studies as Topic; D005191:Family Characteristics; D005260:Female; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008297:Male; D009497:Neurotic Disorders / Q000175:diagnosis; D010817:Physician-Patient Relations; D011379:Prognosis; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000175:diagnosis; D012559:Schizophrenia / Q000175:diagnosis; D012737:Sex Factors; D014481:United States
D000928:Antidepressive Agents; D007099:Imipramine; D002746:Chlorpromazine